Literature DB >> 18855905

Late presentation of retinoblastoma in Malaysia.

Bina S Menon1, Joseph Alagaratnam, Eni Juraida, Mahfuzah Mohamed, Hishamshah Ibrahim, Nyi Nyi Naing.   

Abstract

AIMS: The aims of this study were to review the presenting features, treatment and outcome for Malaysian children with retinoblastoma currently. SUBJECTS AND METHODS: This was a prospective study, conducted at the General Hospital Kuala Lumpur from August 2001 until October 2007. Clinical data were collected at presentation and follow-up.
RESULTS: One hundred five children were diagnosed to have retinoblastoma. There were 55 males and 50 females, ranging in age from 1 month to 14 years (median 20 months). Seventy-six children were Malay in ethnic origin (73%), 14 Chinese (13%), 12 Indian (11%), and other races (3%). Sixty-four children presented with leukocoria (61%), followed by 23 with proptosis (22%), 13 with squint (12%), and 3 with orbital cellulitis (3%). Thirty-three children (31%) deferred treatment for 6 months or more. Overall, 56 children had extraocular disease (55%), 52 at presentation, 4 later. Seventy-one children (68%) underwent primary enucleation, 76 received chemotherapy (72%), and 23 radiotherapy (22%). Fifty-seven children are alive (54%), of whom 3 are blind (5%). Twenty-seven children were lost to follow-up (26%) and 21 have died (20%).
CONCLUSION: Retinoblastoma in Malaysia is still characterized by predominantly extraocular disease due to late presentation and high rates of abandonment. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18855905     DOI: 10.1002/pbc.21791

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  12 in total

1.  Extraocular retinoblastoma in Indian children: clinical, imaging and histopathological features.

Authors:  Sumita Sethi; Neelam Pushker; Seema Kashyap; Sanjay Sharma; Mridula Mehta; Sameer Bakhshi; Saurbhi Khurana; Supriyo Ghose
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Retinoblastoma: concerning its initiation and treatment.

Authors:  Chang Luo; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 3.  Focal laser treatment in addition to chemotherapy for retinoblastoma.

Authors:  Ido D Fabian; Kenneth P Johnson; Andrew W Stacey; Mandeep S Sagoo; M A Reddy
Journal:  Cochrane Database Syst Rev       Date:  2017-06-07

4.  "Retinoblastoma survival disparity": The expanding horizon in developing countries.

Authors:  Masood Naseripour
Journal:  Saudi J Ophthalmol       Date:  2012-02-18

5.  Retinoblastoma in the democratic republic of congo: 20-year review from a tertiary hospital in kinshasa.

Authors:  Aimé Kazadi Lukusa; Michel Ntetani Aloni; Bertin Kadima-Tshimanga; Moïse Mvitu-Muaka; Jean Lambert Gini Ehungu; René Ngiyulu; Pépé Ekulu Mfutu; Aléine Budiongo Nzazi
Journal:  J Cancer Epidemiol       Date:  2012-04-26

6.  Quercetin inhibits angiogenesis-mediated human retinoblastoma growth by targeting vascular endothelial growth factor receptor.

Authors:  Wei Song; Xiaofei Zhao; Jiarui Xu; Han Zhang
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

7.  Epidemiological Characteristics of Retinoblastoma in Children Attending Almouassat University Hospital, Damascus, Syria, 2012-2016

Authors:  Ahmad Al Hasan; Rashad Murad; Khaldoun Zaid; Jourjous Al Daoud; Khaled Zaid
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

8.  Extra-ocular retinoblastoma: about 12 cases followed at the Mohamed VI university hospital of Marrakech.

Authors:  Soltani Leila; Hajji Ibtissam; Essafi Hafsa; Moutaouakil Abdeljalil
Journal:  Pan Afr Med J       Date:  2016-11-02

9.  Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India.

Authors:  Usha Singh; Deeksha Katoch; Savleen Kaur; Mangat Ram Dogra; Deepak Bansal; Rakesh Kapoor
Journal:  Ocul Oncol Pathol       Date:  2017-07-05

10.  Spectrum of germ-line RB1 gene mutations in Malaysian patients with retinoblastoma.

Authors:  Mohd Khairul Nizam Mohd Khalid; Yusnita Yakob; Rohani Md Yasin; Keng Wee Teik; Ch'ng Gaik Siew; Jamalia Rahmat; Sunder Ramasamy; Joseph Alagaratnam
Journal:  Mol Vis       Date:  2015-10-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.